Table 1.
Cardiac function analysis with echocardiography
| Groups | S | B | A | AL | AA |
|---|---|---|---|---|---|
|
Before AMI | |||||
|
LVEF(%) |
70.52±2.09 |
69.27±2.33 |
68.75±3.01 |
70.11±2.67 |
69.35±2.82 |
|
FS(%) |
35.98±3.15 |
34.83±4.02 |
37.09±3.73 |
36.62±4.09 |
35.26±3.35 |
|
LVVs(ml) |
2.03±0.27 |
1.99±0.35 |
2.16±0.31 |
2.08±0.30 |
2.05±0.28 |
|
LVVd(ml) |
5.76±0.30 |
5.97±0.38 |
5.85±0.41 |
5.81±0.34 |
5.85±0.31 |
|
CO(ml) |
3.72±0.18 |
3.98±0.27 |
3.69±0.22 |
3.73±0.21 |
3.81±0.25 |
|
HR(bpm) |
454±68 |
462±59 |
455±61 |
466±78 |
459±71 |
|
One day after AMI | |||||
|
LVEF(%) |
69.51±1.94 |
46.13±2.61* |
45.26±2.44* |
46.09±2.72* |
45.68±2.59* |
|
FS(%) |
35.78±3.23 |
25.71±3.06* |
26.07±2.99* |
25.22±3.30* |
24.97±3.26* |
|
LVVs(ml) |
2.08±0.31 |
3.52±0.31* |
3.47±0.36* |
3.56±0.29* |
3.45±0.30* |
|
LVVd(ml) |
5.82±0.27 |
6.49±0.37* |
6.71±0.35* |
6.55±0.42* |
6.61±0.39* |
|
CO(ml) |
3.74±0.19 |
2.97±0.22* |
3.24±0.27* |
2.99±0.24* |
3.16±0.25* |
|
HR(bpm) |
461±70 |
536±67 |
551±56 |
549±62 |
541±71 |
|
Seven days after AMI | |||||
|
LVEF(%) |
70.07±2.11 |
44.91±2.72* |
55.57±3.61*# |
49.98±3.03*#$ |
48.98±2.87*#$ |
|
FS(%) |
36.09±3.12 |
23.96±3.41* |
32.58±3.35# |
27.20±3.27*#$ |
27.86±3.32*#$ |
|
LVVs(ml) |
2.04±0.25 |
3.63±0.37* |
2.71±0.53*# |
3.11±0.46*# |
3.18±0.41*# |
|
LVVd(ml) |
5.67±0.23 |
6.53±0.29* |
6.03±0.28*# |
6.26±0.24* |
6.41±0.26*$ |
|
CO(ml) |
3.63±0.21 |
2.90±0.24* |
3.32±0.31 |
3.09±0.26* |
3.23±0.29*#$ |
| HR(bpm) | 457±63 | 547±66 | 488±57 | 517±68 | 522±63 |
· * P<0.05 vs. Sham group.
· # P<0.05 vs. Blank Control group.
· $ P<0.05 vs. Atorvastatin group.
· S=Sham operated group; B=Blank control group; A=Atorvastatin group; AL=Atorvastatin+L-NAME group; AA=Atorvastatin+AMD3100 group.